SOURCE: Fresh Start Private Management, Inc.

Fresh Start Private Management,  Inc.

November 08, 2013 08:00 ET

Fresh Start Private Management, Inc. Update on Progress of Connecticut Licensing Agreement

LOS ANGELES, CA--(Marketwired - Nov 8, 2013) - Fresh Start Private Management Inc. (OTCQB: CEYY), a leader in alcohol treatment and rehabilitation programs, announced yesterday that it had entered into a letter of intent to sell the exclusive license and distribution rights of its alcohol treatment program to JPL, LLC. Under the terms of the pending agreement, JPL, LLC will agree to pay Fresh Start Private an upfront licensing fee and running royalties on all program sales in the state of Connecticut.

Fresh Start Private is reporting that JPL has begun clinic location scouting and has placed a substantial good faith deposit towards the upfront license fee. Both the total amount of the upfront licensing fee, and the running royalty amount have been agreed to by both parties. Final due diligence and contract completion are now underway.

"This deal is moving along really quickly and we hope to get it completed before the holidays," said Kent Emry, CEO of Fresh Start Private Management, Inc. "In the last month, we have been fielding many inquiries from interested parties who desire licensing deals in specific territories of their respective interest. It's a great position to be in as it validates our mission and it helps us with our plan for broad distribution in the U.S. and abroad so that more families can be helped with their battle against alcoholism."

About Fresh Start Private

Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, please visit

Safe Harbor Statement

The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Contact Information

  • Investor Relations Contact:
    Maximum Performance Advisors, Inc.